CAH's specialty growth, strong pharma demand and expanding services portfolio are driving earnings momentum and positioning it for sustained long-term growth.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
CAH expands Ac-225 capacity, boosting its role in radiopharma as rising clinical demand and future cancer therapy commercialization drive growth.
CAH's specialty flywheel strategy links distribution, MSOs and biopharma services, boosting partnerships, drug launches and recurring revenue potential.
In the latest trading session, Cardinal Health (CAH) closed at $211.31, marking a +2.42% move from the previous day.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
CAH's $1.8 billion free cash flow fuels buybacks, dividends, and reinvestment, as Cardinal Health eyes disciplined capital deployment and targeted growth opportunities.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
In the most recent trading session, Cardinal Health (CAH) closed at $211.87, indicating a -2.08% shift from the previous trading day.
California Public Employees Retirement System lowered its holdings in Cardinal Health, Inc. (NYSE: CAH) by 17.0% in the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 791,274 shares of the company's stock after selling 162,634 shares during the period. California Public Employees Retirement System owned
Defense plays Karman Holdings and General Dynamics are among five stocks to watch as the Iran war drives stock market action.